We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $481B
1-Year Est. Return 30.42%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
+24.08%
1 Year Est. Return
+30.42%
3 Year Est. Return
+88.16%
5 Year Est. Return
+120.13%
10 Year Est. Return
+468.8%
AUM
$228B
AUM Growth
+$35.6B
Cap. Flow
-$2.49B
Cap. Flow %
-1.09%
Top 10 Hldgs %
11.61%
Holding
3,428
New
54
Increased
1,496
Reduced
1,641
Closed
89

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$214M
2
VZ icon
Verizon
VZ
+$148M
3
OTIS icon
Otis Worldwide
OTIS
+$142M
4
BIDU icon
Baidu
BIDU
+$124M
5
BABA icon
Alibaba
BABA
+$120M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$324M
2
AMZN icon
Amazon
AMZN
+$313M
3
BAC icon
Bank of America
BAC
+$264M
4
AGN
Allergan plc
AGN
+$259M
5
WFC icon
Wells Fargo
WFC
+$257M

Sector Composition

Rank Sector Weight
1 Technology 16.39%
2 Financials 16.29%
3 Industrials 12.76%
4 Healthcare 11.61%
5 Consumer Discretionary 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOVE icon
3201
LoveSac
LOVE
$248M
$223K ﹤0.01%
+8,500
New +$129K
NGM
3202
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$223K ﹤0.01%
+11,316
New +$216K
AXLA
3203
DELISTED
Axcella Health Inc. Common Stock
AXLA
$220K ﹤0.01%
+1,590
New +$195K
TRQ
3204
DELISTED
Turquoise Hill Resources Ltd
TRQ
$218K ﹤0.01%
29,693
CEMI
3205
DELISTED
Chembio diagnostics, Inc.
CEMI
$218K ﹤0.01%
67,088
AWX icon
3206
Avalon Holdings
AWX
$10.1M
$214K ﹤0.01%
132,654
-1,246
-0.9% -$1.8K
KOSS icon
3207
Koss Corp
KOSS
$35.2M
$212K ﹤0.01%
158,152
-8,899
-5% -$10.9K
OMAB icon
3208
Grupo Aeroportuario Centro Norte
OMAB
$5.23B
$208K ﹤0.01%
+5,610
New +$181K
SLDB icon
3209
Solid Biosciences
SLDB
$785M
$204K ﹤0.01%
4,642
+3,336
+255% +$139K
MJCO
3210
DELISTED
Majesco
MJCO
$198K ﹤0.01%
25,242
+2,000
+9% +$12.6K
MSN icon
3211
Emerson Radio
MSN
$8.19M
$197K ﹤0.01%
293,474
-152,487
-34% -$110K
FFBW
3212
DELISTED
FFBW, Inc. Common Stock
FFBW
$195K ﹤0.01%
22,636
SCPH
3213
DELISTED
scPharmaceuticals
SCPH
$194K ﹤0.01%
26,350
+10,480
+66% +$92.1K
FUSB icon
3214
First US Bancshares
FUSB
$91.9M
$188K ﹤0.01%
27,188
DRD
3215
DRDGold
DRD
$1.79B
$187K ﹤0.01%
+11,857
New +$117K
AXIA.PR
3216
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$185K ﹤0.01%
31,856
-2,739
-8% -$14.5K
ZYNE
3217
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$185K ﹤0.01%
54,866
-8,462
-13% -$40K
SHSP
3218
DELISTED
SharpSpring, Inc.
SHSP
$185K ﹤0.01%
21,063
+1,300
+7% +$10.2K
HROW icon
3219
Harrow
HROW
$1.47B
$184K ﹤0.01%
+35,375
New +$174K
BINI
3220
DELISTED
Bollinger Innovations
BINI
0
SELF
3221
Global Self Storage
SELF
$58.1M
$181K ﹤0.01%
46,170
+2,689
+6% +$10.2K
PHAS
3222
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$181K ﹤0.01%
+39,348
New +$174K
FRAN
3223
DELISTED
Francesca's Holdings Corporation
FRAN
$179K ﹤0.01%
46,400
-46,935
-50% -$144K
DXLG icon
3224
Destination XL Group
DXLG
$34.3M
$178K ﹤0.01%
273,660
-1,034,515
-79% -$459K
NNA
3225
DELISTED
Navios Maritime Acquisition Corporation
NNA
$178K ﹤0.01%
43,705
+4,533
+12% +$22.3K

Similar funds

Dimensional Fund Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Dimensional Fund Advisors held 3,428 positions worth $228B, up 19% from $192B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 4.2%. Dimensional Fund Advisors opened 54 new positions and exited 89, leaving the 3,428-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

  • Dimensional Fund Advisors's largest Q2 2020 buy was Otis Worldwide: 2,746,401 shares worth $156M.
  • Dimensional Fund Advisors added most to AbbVie in Q2 2020, an estimated $214M increase.
  • Dimensional Fund Advisors's biggest Q2 2020 reduction was Apple, cutting an estimated $324M.
  • Dimensional Fund Advisors fully exited Allergan plc in Q2 2020, selling an estimated $259M.
  • Dimensional Fund Advisors's ten largest holdings make up 12% of its $228B portfolio in Q2 2020.
  • Dimensional Fund Advisors opened 54 new positions and closed 89 in Q2 2020.
  • Dimensional Fund Advisors's portfolio value rose 19% quarter-over-quarter to $228B.

Based on Dimensional Fund Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.